Philippines Hemodialysis Equipment Market Analysis

Philippines Hemodialysis Equipment Market Executive Summary

The Philippines Hemodialysis Equipment Market is at around $31.1 Mn in 2023 and is projected to reach $53.6 Mn in 2030, exhibiting a CAGR of 8.1% during the forecast period 2023-2030.

Patients with kidney failure can receive hemodialysis, a potentially life-saving medical therapy. It replaces the body's lost kidney function artificially by eliminating waste materials and extra fluid while preserving the right electrolyte balance. The procedure entails creating a surgical vascular access, usually in the arm, to access the patient's bloodstream. After that, blood is pushed through a dialyzer, sometimes known as an artificial kidney. Thousands of hollow threads in this device filter the blood, eliminating waste and extra fluid. After cleaning, the blood is put back into the body. Hemodialysis treatments are normally conducted three times a week and take three to five hours each time. The length and frequency may change according to each patient's demands.

Side effects can include low blood pressure, muscle cramps, and fatigue. Dietary restrictions and medication management are often necessary alongside dialysis treatment. While hemodialysis is not a cure for kidney failure, it effectively manages the condition, allowing many patients to lead active lives. It's often used as a long-term treatment or as a bridge to kidney transplantation. Ongoing research aims to improve dialysis technology and patient outcomes.

CKD is among the leading causes of sickness and death in the Philippines. Latest estimates show that around 2.3 Mn Filipinos have CKD. The hemodialysis market is driven by significant factors like aging population, increase prevalence rate of chronic diseases, increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth.

Some of the major players operating in the Philippines Hemodialysis Equipment Market are Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd, Nipro Corp, DaVita, among others.

Market Dynamics

Rising Prevalence of Chronic Kidney Disease and ESRD: The prevalence of chronic kidney disease in the Philippines is estimated to be around 11-13% of the population, with diabetes and glomerulonephritis being the leading causes of ESRD. The number of patients on dialysis in the Philippines has increased from around 10,000 in 2000 to over 40,000 in 2021, reaching around 370 patients per 1 Mn population.

High Incidence of Diabetes: The Philippines has a high incidence of diabetes, with a prevalence of around 6.3% of the adult population as of 2021. Diabetes is a major risk factor for kidney disease, and the high prevalence of diabetes is a key driver of the growing dialysis market in the Philippines.

Aging Population: The proportion of residents aged 65 and above in the Philippines is expected to increase from 4.9% in 2020 to 6.8% by 2030. The growing elderly population is more susceptible to chronic kidney disease, contributing to the demand for dialysis services.

Market Restraints

Shortage of Kidney Donors: The limited availability of kidney donors for transplants makes dialysis the primary treatment option, but also constrains the market as some patients may opt for transplants if more donors were available.

Lack of Awareness and Education: Limited awareness and education about chronic kidney disease and the importance of early detection and management can lead to late referrals and increased complications, which can negatively impact the dialysis market.

Infrastructure and Resource Challenges: Inadequate infrastructure, such as a lack of dialysis centers and trained healthcare professionals, can limit access to dialysis services and constrain market growth.

Regulatory Landscape and Reimbursement Scenario

The Philippines regulates medical devices through its Food and Drug Administration (FDA), categorizing them into Classes A to D based on risk, with hemodialysis equipment typically in higher risk classes. Registration requirements include technical documentation, quality management system certification, risk management files, clinical evidence for high-risk devices, labeling information, and a Certificate of Free Sale from the country of origin. The FDA conducts post-market surveillance and requires adverse event reporting, while foreign manufacturers must have local representatives.

For hemodialysis reimbursement, PhilHealth's Z Benefits package covers 90 sessions per year for outpatient hemodialysis, with a fixed amount per session (around PHP 2,600). However, this coverage is often insufficient, and patients must meet specific criteria. Supplementary options include private health insurance, HMOs, DSWD assistance for indigent patients, and local government health programs. The Philippine Kidney and Transplant Institute offers subsidized rates for qualifying patients, and some hospitals have charity programs. Despite these mechanisms, many patients face significant out-of-pocket expenses. The government is working to expand coverage and improve access, but achieving comprehensive, affordable hemodialysis care nationwide remains challenging due to limited resources and geographical disparities in healthcare access.

Competitive Landscape

Key Players

Here are some of the major key players in the Philippines Hemodialysis Equipment Market:

• Asahi Kasei Corporation
• Becton Dickinson Company
• Deutschland Gmbh
• Fresenius Medical Care
• Baxter International
• B. Braun
• Nipro Corporation
• Nikkiso Co., Ltd.
• Medtronic
• Diaverum
• DaVita Inc.